Wellness company Hello Heart has raised $12 million in new funding that will go toward developing at-home monitoring solutions and behavioral treatments for hypertension, TechCrunch reported July 31.
The money, which came primarily from Khosla Ventures and Hello Heart’s previous backer, Blue Run Ventures, will be used to expand its business, which tackles high BP and heart disease with an at-home sensing system that tracks blood pressure and an integrated smartphone application that provides prompts on behaviors to reduce high blood pressure.
TechCrunch reported that, according to a Hello Heart-funded study, 70% of the company’s users managed to decrease their blood pressure by an average of 22 mmHg.
“Delivering clinical outcomes at the scale of population health requires strong patient engagement across a variety of patient types,” Harvard researcher and physician Eyal Zimlichman said. “Hello Heart’s ability to drive engagement is what led to these unprecedented results.”
Read the full story below: